Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive July 3, 2007	Direct to Consumer: The Secret of My Success Pharmaceutical industry experts sound off on the methods behind an award-winning ad and how the next great direct-to-consumer campaign will come about.
Pharmaceutical Executive March 1, 2009 Walker & Stahl	Activate Your Audience Marketers need to reach beyond disease awareness to spark "movement" communications campaigns.
Pharmaceutical Executive July 1, 2006	Direct to Consumer: Making the Connection Whether it's to promote a drug or help educate the masses, pharmaceutical manufacturers are creating advertising campaigns that tug at people's hearts to get the message out.
Pharmaceutical Executive October 1, 2010	Optimizing TV Advertising Placements & Results Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives.
Pharmaceutical Executive November 1, 2005 Peter H. Nalen	Alternative Media: Targeting Audiences on the Web The most important web page to communicate with doctors and patients is the page of results that your potential customers see when they use search engines, such as Google, Yahoo!, or MSN.
Pharmaceutical Executive April 1, 2012	Ad Stars The campaigns chosen as this year's Pharm Exec Ad Stars include a diverse mix of clients, health conditions, and media channels.
Pharmaceutical Executive March 1, 2011	Ad Stars 2011 Here, the people behind the best of pharma advertising over the past year are acknowledged.
Pharmaceutical Executive June 1, 2012	A Brand Positioning Nightmare New drug indications can be a brand manager's worst nightmare or a dream come true. The difference lies in the perspective and in the branding strategy.
Pharmaceutical Executive January 1, 2013 Al Topin	The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author.
Pharmaceutical Executive September 1, 2008	Bolder is Better Marketers of oncology pharmaceuticals and biologics have moved to the forefront of companies' portfolios. Their advertising campaigns show a new sophistication about branding and marketing.
Pharmaceutical Executive January 1, 2011 Eric Boothe	The Right Mix for 2011 Incorporating the proper blend of media into your marketing initiatives will help to increase the flexibility and success of your pharma marketing campaigns.
U.S. Banker September 2010 Bonnie McGeer	Sounding Reveille Amex's Booming campaign aims to inspire small businesses with tales of others success.
Pharmaceutical Executive October 1, 2011	Patient Advocacy: The Last 30 Years The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Pharmaceutical Executive June 1, 2012 Amy Smith	Marketing: Medical Devices vs. Pharma Understanding the differences between drug and device marketing can make or break the brand's promotional activities.
AFP eWire February 24, 2006	Secrets of Success from a Nonprofit Pioneer Nancy Brinker, founder and self-described veteran volunteer for the Susan G. Komen Breast Cancer Foundation shared her secrets of success: Harness the power of one... Go for grassroots... Change the culture... etc.
Pharmaceutical Executive May 1, 2009 Jay Bigelow	Behavior and the Bottom Line In an era of shrinking marketing budgets, increase ROI with behavioral science-based marketing.
Pharmaceutical Executive September 1, 2012 Al Topin	Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty.
Pharmaceutical Executive August 1, 2013 Peter Houston	The Case for Content Reaching skittish consumers through objective, story driven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges.
CRM September 25, 2010 Dan Hill	The Emotional Path to Success Moving beyond on-message marketing.
CRM October 20, 2010 Juan Martinez	5 Dos and Don'ts of Social Media Marketing Social Ad Summit '10: Is your marketing team really prepared to launch a social media campaign?
Pharmaceutical Executive April 1, 2012 Bill Drummy	Think Digital First While what is considered 'traditional' marketing has evolved over the years, it's clear that a digital strategy is an absolute necessity to compete today; not just tomorrow.
Pharmaceutical Executive May 1, 2009 Maryann Kuzel	Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market.
Pharmaceutical Executive May 1, 2009	Ad(Ventures) in Pharmaland Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration.
Pharmaceutical Executive August 1, 2008 George Koroneos	Hard of (Ad)hering Companies have responded to declining profits with a proliferation of patient compliance programs. But where is pharma in this paradigm shift?
Pharmaceutical Executive July 1, 2005 Ken Dec	Direct to Consumer: Moving House The "House of Brands" model is a house of cards. The pharmaceutical industry should change, or risk losing trust forever.
Pharmaceutical Executive January 1, 2012 Elys Roberts & Sarah Phillips	The Emergence of the Pro-Patient How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?
BusinessWeek August 9, 2004 Gene G. Marcial	MGI Pharma Has Just What Patients Need Its first major drug, an injection to prevent chemotherapy-induced nausea and vomiting, is on fire in a $1.5 billion market. And turning MGI into a moneymaker.
Pharmaceutical Executive June 1, 2009 Michael Maher	Learning to Relate A multi-phase implementation strategy can debunk the myth that social media won't work for pharma.
CRM December 2010 Juan Martinez	No Longer The Text-Best Thing Text messages remain a big part of any mobile campaign, but these days a multichannel approach is what really connects
CRM December 2014 Maria Minsker	The 3 Cardinal Rules of Cause Marketing There's a fine line between giving and gimmick.
Pharmaceutical Executive August 1, 2011 Jennifer Ringler	The Adherence Fight: A TKO? Why does the match against medicines compliance always seem to end in an easy knockout?
Pharmaceutical Executive April 1, 2006 Howard Steinberg	Alternative Media: TV's Targeted Comeback Educational TV programming provides a new channel of information for disease sufferers.
The Motley Fool June 17, 2010 Luke Timmerman	Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials.
Fast Company Courtney Seiter	How Our Brains Decide What We Share Online Google's Abigail Posner says we can't underestimate the importance of understanding the science of emotion in marketing.
Pharmaceutical Executive September 1, 2005 Lydia Worthington	Alternative Media: Mouthing Off Word-of-mouth marketing provides insight into patients' attitudes on drugs and treatments.
Nursing October 2010 Linda Schiech	HPV-related cancer: An equal opportunity danger Although many people know that HPV infections are the leading cause of cervical cancer, they might be surprised to learn that HPV is also associated with other kinds of cancer, including cancers of the head and neck, and anal and penile cancers.
Pharmaceutical Executive October 1, 2008 Andrew Levitt	What's The Buzz What's the buzz all about? Word of mouth is more effective than we think.
Pharmaceutical Executive October 1, 2010	When the Payer IS the Player As Medicare, Medicaid, and the nation's web of private payers gain market power, how can pharma stay ahead of the cost-containment curve?
Pharmaceutical Executive May 1, 2005 Diane West	Media Spend Trends: Changing Lanes You've got their attention---now what? Pharma marketing analysts predict a spending shift from branded direct-to-consumer efforts to more disease awareness and corporate reputation promotions.
Salon.com November 10, 2000 Laurie Tarkan	The business of breast cancer Big medicine is making big bucks on the disease, but we're still far from a cure...
CRM September 3, 2015 Jessica Hawthorne-Castro	With Campaign Metrics, You Need to Go Beyond the Basics Here are four metrics to make your decision making more data-driven -- and enhance profits.
Pharmaceutical Executive February 1, 2012 Sarah Krug	Introducing the 'Chief Patient Officer' Now is the time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust.
The Motley Fool September 25, 2006 Brian Lawler	Merck's Positive Contribution Bad press from Vioxx shouldn't overshadow the company's new offering. Investors, take note.
Pharmaceutical Executive May 1, 2005 Kathy Kastner	Direct to Consumer: Information vs. Education Although the pharma industry is good at providing information, it has not yet learned how to transform it into reliable education. If pharma marketers can initiate that transformation, they will grab a significant opportunity to connect with consumers.
Pharmaceutical Executive December 1, 2005 Meg Columbia-Walsh	Direct to Consumer: Culturally Relevant Marketing Through culturally relevant marketing, pharma can seamlessly weave its brands into consumers' lives... Also: The 2005 Pharmaceutical Advertising and Marketing Excellence Award recipients...
Fast Company November 22, 2011	The Birth Of An Idea: Ads To Rebrand Girls Fast Company asked several of the most creative ad agencies in the world to re-brand baby girls. Their mock campaigns recast girls as the No. 1 choice for consumers from China to the U.S.
BusinessWeek November 29, 2004 Kerry Capell	"A Vaccine Every Woman Should Take" Two drug companies are closing in on shots against HPV, the leading cause of cervical cancer. Despite the obvious benefits, the vaccines may not be an easy sell: There are social and moral hurdles to overcome.
Pharmaceutical Executive May 1, 2006 Joanna Breitstein	Cervical Cancer: Endagered Species Preventive care is more efficient than treating disease after the fact. Now this paradigm takes hold in cancer with new HPV vaccines. Now that the science is in order, Merck and GSK face several important challenges in conditioning the market.
Pharmaceutical Executive July 30, 2007 Stewart Young	Marketing to Professionals: The Essence of a Brand Beyond good messaging, marketers must establish a brand that is forever etched into physicians' minds.
Pharmaceutical Executive September 1, 2012 Robin Hertz	The Endless Treadmill of End-of-Life Care Bending the cost curve back to valuing the cycle of life.